First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery

Author:

Menichincheri Maria1,Bargiotti Alberto1,Berthelsen Jens1,Bertrand Jay A.1,Bossi Roberto1,Ciavolella Antonella1,Cirla Alessandra1,Cristiani Cinzia1,Croci Valter1,D’Alessio Roberto1,Fasolini Marina1,Fiorentini Francesco1,Forte Barbara1,Isacchi Antonella1,Martina Katia1,Molinari Antonio1,Montagnoli Alessia1,Orsini Paolo1,Orzi Fabrizio1,Pesenti Enrico1,Pezzetta Daniele1,Pillan Antonio1,Poggesi Italo1,Roletto Fulvia1,Scolaro Alessandra1,Tatò Marco1,Tibolla Marcellino1,Valsasina Barbara1,Varasi Mario1,Volpi Daniele1,Santocanale Corrado1,Vanotti Ermes1

Affiliation:

1. Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy, Dipartimento di Chimica IFM, Università di Torino, Torino, Italy, GlaxoSmithKline S.p.A., Verona, Italy, Genextra Group S.p.A., Milano, Italy, National Centre for Biomedical Engineering and Sciences, National University of Ireland, Galway, Ireland

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3